Dosage and administration
Wet hands. Apply to hands. Scrub thoroughly. Rinse. Recommended for repeated use.
Wet hands. Apply to hands. Scrub thoroughly. Rinse. Recommended for repeated use.
Triclocarban 0.29%
Antibacterial
For hand washing to decrease bacteria on the skin. Recommended for repeated use.
For external use only. Keep out of reach of children.
Children should use only this product under adult supervision.
Not edible. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.
Avoid contact with broken skin.
When using this product, avoid contact with eyes. In case of eye contact, immediately flush eyes with water, call a doctor.
keep out of reach of children
Wet hands. Apply to hands. Scrub thoroughly. Rinse.
Recommended for repeated use.
Sodium Palmate, Sodium Cocoate, Calcium Carbonate, Water, Glycerin, Fragrance, Sodium Chloride, Edetate Sodium, Etidronic Acid, Titanium Dioxide.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07cba15c-4adc-1039-9ab9-45f5b7e84f4f | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53507-001-01 | DEODORANT | 10 g in 1 PACKAGE | SOAP | 10 | 4 | |
| 53507-001-02 | DEODORANT | 13 g in 1 PACKAGE | SOAP | 13 | 4 | |
| 53507-001-03 | DEODORANT | 20 g in 1 PACKAGE | SOAP | 20 | 4 | |
| 53507-001-04 | DEODORANT | 30 g in 1 PACKAGE | SOAP | 30 | 4 | |
| 53507-001-05 | DEODORANT | 35 g in 1 PACKAGE | SOAP | 35 | 4 | |
| 53507-001-06 | DEODORANT | 54 g in 1 PACKAGE | SOAP | 54 | 4 | |
| 53507-001-07 | DEODORANT | 60 g in 1 PACKAGE | SOAP | 60 | 4 | |
| 53507-001-08 | DEODORANT | 75 g in 1 PACKAGE | SOAP | 75 | 4 | |
| 53507-001-09 | DEODORANT | 85 g in 1 PACKAGE | SOAP | 85 | 4 | |
| 53507-001-10 | DEODORANT | 14.17 g in 1 PACKAGE | SOAP | 14.17 | 4 | |
| 53507-001-11 | DEODORANT | 21.26 g in 1 PACKAGE | SOAP | 21.26 | 4 | |
| 53507-001-12 | DEODORANT | 28.35 g in 1 PACKAGE | SOAP | 28.35 | 4 | |
| 53507-001-13 | DEODORANT | 42.52 g in 1 PACKAGE | SOAP | 42.52 | 4 | |
| 53507-001-14 | DEODORANT | 71 g in 1 PACKAGE | SOAP | 71 | 4 | |
| 53507-001-15 | DEODORANT | 99 g in 1 PACKAGE | SOAP | 99 | 4 | |
| 53507-001-16 | DEODORANT | 113 g in 1 PACKAGE | SOAP | 113 | 4 | |
| 53507-001-17 | DEODORANT | 142 g in 1 PACKAGE | SOAP | 142 | 4 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TRICLOCARBAN | ACTIVE INGREDIENT | BGG1Y1ED0Y | 4 | |
| TRICLOCARBAN | ACTIVE MOIETY | BGG1Y1ED0Y | 4 | |
| Calcium Carbonate | INACTIVE INGREDIENT | H0G9379FGK | 4 | |
| Edetate Sodium | INACTIVE INGREDIENT | MP1J8420LU | 4 | |
| Etidronic Acid | INACTIVE INGREDIENT | M2F465ROXU | 4 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| Sodium Cocoate | INACTIVE INGREDIENT | R1TQH25F4I | 4 | |
| Sodium Palmate | INACTIVE INGREDIENT | S0A6004K3Z | 4 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53507-001 | 53507-001-01, 53507-001-02, 53507-001-03, 53507-001-04, 53507-001-05, 53507-001-06, 53507-001-07, 53507-001-08, 53507-001-09, 53507-001-10, 53507-001-11, 53507-001-12, 53507-001-13, 53507-001-14, 53507-001-15, 53507-001-16, 53507-001-17 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TRICLOCARBAN | BGG1Y1ED0Y | ACTIB |
| WATER | 059QF0KO0R | IACT |
| Sodium Palmate | S0A6004K3Z | IACT |
| Sodium Cocoate | R1TQH25F4I | IACT |
| Calcium Carbonate | H0G9379FGK | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Edetate Sodium | MP1J8420LU | IACT |
| Etidronic Acid | M2F465ROXU | IACT |
| Titanium Dioxide | 15FIX9V2JP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / NASAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRALESIONAL | 0.9 %w/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, EXTENDED RELEASE / ORAL | 229.7 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 45 mg | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | INJECTION, SOLUTION / INTRAVENOUS | 0.04 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, EXTENDED RELEASE / ORAL | 335.1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBCUTANEOUS | 1486 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE / ORAL | 6 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, CHEWABLE / ORAL | 1650 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | SHAMPOO / TOPICAL | 1.33 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / SUBCUTANEOUS | 90 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | FILM, SOLUBLE / ORAL | 14 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | JELLY / NASAL | NA | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET / ORAL | 793 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 755d593f-f508-47f8-b91f-145880662d08 | 6695970f-b333-41e0-86c1-f18b4bfe72ad | 2014-05-26 | Warnings | 755d593f-f508-47f8-b91f-145880662d08 6695970f-b333-41e0-86c1-f18b4bfe72ad |
Adverse event summaries are temporarily unavailable. Other product information remains available.